Moderna's new option is a lower-dose version that is a step toward next-generation coronavirus vaccines. It’s called mNexspike. Moderna’s new COVID-19 vaccine is recommended as another option ...

Patients may be prescribed a short dose of opioid therapy to help manage short-term pain caused by surgery. For patients who may require more extensive or high-dose opioid use, or who have a history ...

Nucala gains new indication; FDA implements stricter guidance for COVID-19 vaccine approval; pruritus reported following discontinuation of long-term antihistamines; antibiotic looks promising for ...

The second cohort will evaluate EB103 at a higher dose level following a review of safety data from the first dose cohort. As previously announced, no dose-limiting toxicities (DLTs) or treatment ...

The incidence of adverse events leading to discontinuation of the trial regimen was 1.5% with the 4-mg mazdutide dose, 0.5% with the 6-mg mazdutide dose, and 1.0% with placebo. A data sharing ...

Pfizer and Moderna are charging up to $150 per dose for a Covid vaccine, according to the CDC’s vaccine price list. The agency doesn’t list the cost of the Novavax vaccine, which was fully ...

Will I Have to Start Back at the Lowest Dose if I Switch From a Compounded to a Brand Name GLP-1? For people who are prescribed a GLP-1 and are able to afford it, the starting dose on the branded ...

Novo Nordisk is ramping up its war on compounders making versions of its top-selling semaglutide medicine as the regulatory grace period for their products officially ends. The Danish drugmaker on ...

We aimed to assess the effectiveness of various doses and administration frequencies in patients with sepsis using a network meta-analysis (NMA) to offer therapeutic prescription guidance. Methods: We ...

Some say annual booster shots are not worth the risk for healthy people. In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots ...

Here, he highlights a significant increase in the implementation of dose optimization plans from less than 20% of protocols in 2021 to the vast majority in 2024, following the announcement and ...